BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18550376)

  • 1. QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds.
    Katritzky AR; Slavov SH; Dobchev DA; Karelson M
    Bioorg Med Chem; 2008 Jul; 16(14):7055-69. PubMed ID: 18550376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial neural networks in prediction of antifungal activity of a series of pyridine derivatives against Candida albicans.
    Buciński A; Socha A; Wnuk M; Baczek T; Nowaczyk A; Krysiński J; Goryński K; Koba M
    J Microbiol Methods; 2009 Jan; 76(1):25-9. PubMed ID: 18824043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR analysis for heterocyclic antifungals.
    Duchowicz PR; Vitale MG; Castro EA; Fernández M; Caballero J
    Bioorg Med Chem; 2007 Apr; 15(7):2680-9. PubMed ID: 17296301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study of antimicrobial activity of some 3-nitrocoumarins and related compounds.
    Debeljak Z; Skrbo A; Jasprica I; Mornar A; Plecko V; Banjanac M; Medić-Sarić M
    J Chem Inf Model; 2007; 47(3):918-26. PubMed ID: 17489552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSARs of some novel isosteric heterocyclics with antifungal activity.
    Yalçin I; Oren I; Temiz O; Sener EA
    Acta Biochim Pol; 2000; 47(2):481-6. PubMed ID: 11051213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial activity: a QSAR modeling using CODESSA PRO software.
    Katritzky AR; Kulshyn OV; Stoyanova-Slavova I; Dobchev DA; Kuanar M; Fara DC; Karelson M
    Bioorg Med Chem; 2006 Apr; 14(7):2333-57. PubMed ID: 16426851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
    Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT
    J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
    Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
    Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSPR modeling of flash points: an update.
    Katritzky AR; Stoyanova-Slavova IB; Dobchev DA; Karelson M
    J Mol Graph Model; 2007 Sep; 26(2):529-36. PubMed ID: 17532242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity, mechanism and QSAR studies on chalcones.
    Sivakumar PM; Muthu Kumar T; Doble M
    Chem Biol Drug Des; 2009 Jul; 74(1):68-79. PubMed ID: 19519746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study.
    Tafi A; Anastassopoulou J; Theophanides T; Botta M; Corelli F; Massa S; Artico M; Costi R; Di Santo R; Ragno R
    J Med Chem; 1996 Mar; 39(6):1227-35. PubMed ID: 8632429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of 3D-QSAR study and recursive partitioning of heterocyclic quinone derivatives with antifungal activity.
    Choi SY; Shin JH; Ryu CK; Nam KY; No KT; Park Choo HY
    Bioorg Med Chem; 2006 Mar; 14(5):1608-17. PubMed ID: 16263301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity of conjugated styryl ketones.
    Manavathu EK; McDonald LA; Gunasekaran S; Gunasekaran M
    Indian J Exp Biol; 1997 Apr; 35(4):361-5. PubMed ID: 9315235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of artemisinin derivatives.
    Galal AM; Ross SA; Jacob M; ElSohly MA
    J Nat Prod; 2005 Aug; 68(8):1274-6. PubMed ID: 16124777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some new isoxazoline derivatives as possible anti-Candida agents.
    Sharma PC; Sharma SV; Jain S; Singh D; Suresh B
    Acta Pol Pharm; 2009; 66(1):101-4. PubMed ID: 19226977
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative structure-activity relationships study of a series of imidazole derivatives as potential new antifungal drugs.
    Wiktorowicz W; Markuszewsk- M; Krysiński J; Kaliszan R
    Acta Pol Pharm; 2002; 59(4):295-306. PubMed ID: 12403305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR study on tadpole narcosis using PI index: a case of heterogenous set of compounds.
    Jaiswal M; Khadikar P
    Bioorg Med Chem; 2004 Apr; 12(7):1731-6. PubMed ID: 15028264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes.
    Lapinsh M; Prusis P; Mutule I; Mutulis F; Wikberg JE
    J Med Chem; 2003 Jun; 46(13):2572-9. PubMed ID: 12801221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QNA-based 'Star Track' QSAR approach.
    Filimonov DA; Zakharov AV; Lagunin AA; Poroikov VV
    SAR QSAR Environ Res; 2009 Oct; 20(7-8):679-709. PubMed ID: 20024804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.